BCR and B-cell chronic lymphocytic leukemia: Furthermore, stratifying these samples by ATM monoallelic or biallelic inactivation, we observed that CLL cells harboring ATM biallelic inactivation were even more sensitive to dual BCR and PARP inhibition (Fig. 4b).